TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain MetastasesRachel A. Freedman, Nancy U. Lin, Heather A. Parsons et al.|Journal of Clinical Oncology|2019Cited by 341
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022Rachel A. Freedman, Nancy U. Lin, Rebecca Gelman et al.|Clinical Breast Cancer|2019Cited by 28